Gibula-Tarlowska E, Kotlinska J
Biomolecules. 2020; 10(10).
PMID: 32998249
PMC: 7599993.
DOI: 10.3390/biom10101376.
Xu H, Brown A, Waddell N, Liu X, Kaplan G, Chitaman J
Biol Psychiatry. 2020; 88(10):758-766.
PMID: 32711952
PMC: 7584769.
DOI: 10.1016/j.biopsych.2020.05.004.
Valenza M, Windisch K, Butelman E, Reed B, Kreek M
Psychopharmacology (Berl). 2020; 237(4):1147-1160.
PMID: 31915862
DOI: 10.1007/s00213-019-05444-4.
Liu S, Pickens S, Burma N, Ibarra-Lecue I, Yang H, Xue L
J Neurosci. 2019; 39(21):4162-4178.
PMID: 30862664
PMC: 6529867.
DOI: 10.1523/JNEUROSCI.0274-19.2019.
Dang D, Shin E, Kim D, Tran H, Jeong J, Jang C
J Neuroinflammation. 2018; 15(1):52.
PMID: 29467000
PMC: 5822489.
DOI: 10.1186/s12974-018-1087-7.
The Nociceptin Receptor as an Emerging Molecular Target for Cocaine Addiction.
Lutfy K, Zaveri N
Prog Mol Biol Transl Sci. 2016; 137:149-81.
PMID: 26810001
PMC: 5555398.
DOI: 10.1016/bs.pmbts.2015.10.003.
The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.
Morani A, Ewald A, Prevatt-Smith K, Prisinzano T, Kivell B
Eur J Pharmacol. 2013; 720(1-3):69-76.
PMID: 24201308
PMC: 3899895.
DOI: 10.1016/j.ejphar.2013.10.050.
The mu/kappa agonist nalbuphine attenuates sensitization to the behavioral effects of cocaine.
Smith M, Cole K, Iordanou J, Kerns D, Newsom P, Peitz G
Pharmacol Biochem Behav. 2013; 104:40-6.
PMID: 23305678
PMC: 3606075.
DOI: 10.1016/j.pbb.2012.12.026.
Kappa Opioid Receptor-Mediated Disruption of Novel Object Recognition: Relevance for Psychostimulant Treatment.
Paris J, Reilley K, McLaughlin J
J Addict Res Ther. 2012; S4.
PMID: 22900234
PMC: 3418884.
DOI: 10.4172/2155-6105.S4-007.
Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.
Ranganathan M, Schnakenberg A, Skosnik P, Cohen B, Pittman B, Sewell R
Biol Psychiatry. 2012; 72(10):871-9.
PMID: 22817868
PMC: 3638802.
DOI: 10.1016/j.biopsych.2012.06.012.
The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?.
Yoo J, Kitchen I, Bailey A
Br J Pharmacol. 2012; 166(7):1993-2014.
PMID: 22428846
PMC: 3402766.
DOI: 10.1111/j.1476-5381.2012.01952.x.
A single injection of a novel κ opioid receptor agonist salvinorin A attenuates the expression of cocaine-induced behavioral sensitization in rats.
Morani A, Schenk S, Prisinzano T, Kivell B
Behav Pharmacol. 2012; 23(2):162-70.
PMID: 22293826
PMC: 3306836.
DOI: 10.1097/FBP.0b013e3283512c1e.
Activation of mu opioid receptors in the striatum differentially augments methamphetamine-induced gene expression and enhances stereotypic behavior.
Horner K, Hebbard J, Logan A, Vanchipurakel G, Gilbert Y
J Neurochem. 2011; 120(5):779-94.
PMID: 22150526
PMC: 3711089.
DOI: 10.1111/j.1471-4159.2011.07620.x.
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.
Tejeda H, Shippenberg T, Henriksson R
Cell Mol Life Sci. 2011; 69(6):857-96.
PMID: 22002579
PMC: 11114766.
DOI: 10.1007/s00018-011-0844-x.
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham C, Rothman R, Prisinzano T
Pharmacol Rev. 2011; 63(2):316-47.
PMID: 21444610
PMC: 3082450.
DOI: 10.1124/pr.110.003244.
The role of kappa-opioid receptor activation in mediating antinociception and addiction.
Wang Y, Sun J, Tao Y, Chi Z, Liu J
Acta Pharmacol Sin. 2010; 31(9):1065-70.
PMID: 20729876
PMC: 4002313.
DOI: 10.1038/aps.2010.138.
Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study.
Cortez A, Charntikov S, Der-Ghazarian T, Horn L, Crawford C, McDougall S
Neuroscience. 2010; 169(1):203-13.
PMID: 20435099
PMC: 2900406.
DOI: 10.1016/j.neuroscience.2010.04.052.
Estradiol: a key biological substrate mediating the response to cocaine in female rats.
Segarra A, Agosto-Rivera J, Febo M, Lugo-Escobar N, Menendez-Delmestre R, Puig-Ramos A
Horm Behav. 2009; 58(1):33-43.
PMID: 20026119
PMC: 3621914.
DOI: 10.1016/j.yhbeh.2009.12.003.
kappa-Opioid receptor signaling and brain reward function.
Bruijnzeel A
Brain Res Rev. 2009; 62(1):127-46.
PMID: 19804796
PMC: 2787673.
DOI: 10.1016/j.brainresrev.2009.09.008.
Effect of kappa-opioid receptor agonists U69593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats.
Morani A, Kivell B, Prisinzano T, Schenk S
Pharmacol Biochem Behav. 2009; 94(2):244-9.
PMID: 19747933
PMC: 3021564.
DOI: 10.1016/j.pbb.2009.09.002.